MagForce AG Completes Share Placement
(Thomson Reuters ONE) -
MagForce Nanotechnologies AG /
MagForce AG Completes Share Placement
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Announcement in accordance with section 17 para. 2 of the General Terms and
Conditions of Deutsche Börse AG for the Regulated Unofficial Market on the
Frankfurt Stock Exchange
Berlin, Sept 19, 2011 - MagForce AG (FSE:MF6), a leading medical technology
company focusing on nanomedicine in oncology, has completed a share placement
from its authorized capital. In connection with the transaction, the company's
nominal capital increased from EUR 4,070,681, divided into 4,070,681 no par
value common shares in bearer form with an imputed nominal value of EUR 1.00 by
EUR 56,360.00 to EUR 4,127,041.00. Dr. Peter Heinrich, CEO of MagForce AG, along
with international investors participated in the share placement. The company
excluded subscription rights to existing shareholders by its authority under
sec. 6 para. 4 of its articles of incorporation (Satzung).
A total of 56,360.00 new common bearer shares with profit participation rights
dating from January 1, 2011 were issued in the private placement at a price of
EUR 12.42 per share. The gross proceeds of the capital increase in the amount of
approx. EUR 700,000.00 will go to the company and will be used to finance its
further growth.
ABOUT MAGFORCE:
MagForce AG is a leading medical technology company focusing on nanomedicine in
oncology. The company's proprietary procedure, NanoTherm® therapy, enables the
targeted treatment of solid tumors through the intratumoral release of heat from
magnetic nanoparticles. NanoTherm(®), NanoPlan(®), and NanoActivator(TM) are
components of the therapy and have received EU-wide regulatory approval as
medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan
and NanoActivator are trademarks of MagForce AG in selected countries.
DISCLAIMER:
This release may contain forward-looking statements and information which may be
identified by formulations using terms such as "expects", "aims", "anticipates",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-
looking statements are based on our current expectations and certain assumptions
which may be subject to a variety of risks and uncertainties. The results
actually achieved by MagForce Nanotechnologies AG may substantially differ from
these forward-looking statements. MagForce Nanotechnologies AG assumes no
obligation to update these forward-looking statements or to correct them in case
of developments which differ from those anticipated.
Contact:
Stacy Wiedenmann
Director Investor Relations & Corporate Communications
Magforce AG
Max-Dohrn-Str. 8
10589 Berlin
T +49 30 308 380 31
F +49 30 308 380 99
M +49 151 12000 722
email:swiedenmann(at)magforce.com
www.magforce.com
--- End of Message ---
MagForce Nanotechnologies AG
Max-Dohrn-Str. 8 Berlin Germany
Listed: Open Market (Freiverkehr) in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MagForce Nanotechnologies AG via Thomson Reuters ONE
[HUG#1547452]
Unternehmensinformation / Kurzprofil:
Datum: 19.09.2011 - 10:00 Uhr
Sprache: Deutsch
News-ID 66883
Anzahl Zeichen: 4004
contact information:
Town:
Berlin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 213 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MagForce AG Completes Share Placement"
steht unter der journalistisch-redaktionellen Verantwortung von
MagForce Nanotechnologies AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
